View Agent
| Agent Info | |
| Agent: | cediranib |
| Synonyms: | Recentin;AZD 2171;AZD2171;M6294;AZD-2171;ZD-2171;AZD2171, Recentin, Cediranib;Cediranib (USAN/INN);4-[(4-fluoro-2-methyl-1H-indol-5-yl)oxy]-6-methoxy-7-(3-pyrrolidin-1-ylpropoxy)quinazoline;4-[(4-fluoro-2-methyl-1H-indol-5-yl)oxy]-6-methoxy-7-[3-(pyrrolidin-1-yl)propoxy]quinazoline |
| Drug Status For Certain Diseases: | phase III(Fallopian tube cancer;Ovarian cancer;Peritoneal cavity cancer ) |
| Classification: | a potent inhibitor of vascular endothelial growth factor receptors |
| Target: | Vascular endothelial growth factor receptor 2 |
| KEGG Pathway: | PI3K-Akt signaling pathway VEGF signaling pathway Ras signaling pathway Rap1 signaling pathway Endocytosis |
| Wiki Pathway: | Angiogenesis Signaling by VEGF Nifedipine Activity Focal Adhesion Cardiac Progenitor Differentiation |